REDUCE LAP-HF TRIAL II
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marty Leon, MD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
91 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Concord Hospital
Camperdown, New South Wales, Australia
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- John Hunter Hospital
Newcastle, New South Wales, Australia
- St. Vincent Hospital
Sydney, New South Wales, Australia
- the Prince Charles Hospital
Brisbane, Queensland, Australia
- the Alfred Hospital
Melbourne, Victoria, Australia
- Medizinische Universität Graz
Graz, Austria
- Olvz Aalst
Aalst, Belgium
- Az Sint-Jan Brugge
Bruges, Belgium
- Hamilton Health Sciences
Hamilton, Ontario, Canada
- University Hospital Center, Zagreb
Zagreb, Croatia
- Rigshospitalet
Copenhagen, Denmark
- Chu de Dijon
Dijon, France
- Chu de Nantes
Nantes, France
- Hôpital Bichat
Paris, France
- Hôpital la Pitié Salpétrière
Paris, France
- Chu de Rennes
Rennes, France
- Chu de Rouen
Rouen, France
- Kerckhoff Klinik
Bad Nauheim, Germany
- Charite Universitatsmedizin Berlin
Berlin, Germany
- Unfallkrankenhaus Berlin
Berlin, Germany
- Universitatklinikum Duseldorf
Düsseldorf, Germany
- Heart Center Freiburg University
Freiburg im Breisgau, Germany
- Georg-August-Universitat
Göttingen, Germany
- Cardiologicum Crc
Hamburg, Germany
- Uke Hamburg
Hamburg, Germany
- University of Heidelberg
Heidelberg, Germany
- Heart Center of the University of Leipzig
Leipzig, Germany
- Klinikum Der Universität Munchen
Munich, Germany
- University of Milano
Milan, Italy
- Hokkaido University Hospital
Sapporo, Hokkaido, Japan
- Kyushu University Hospital
Fukuoka, Japan
- the Hospital of Hyogo College of Medicine
Hyōgo, Japan
- Nara Medical University Hospital
Nara, Japan
- National Cerebral and Cardiovascular Center
Osaka, Japan
- Osaka University Hospital
Osaka, Japan
- the University of Tokyo Hospital
Tokyo, Japan
- Tottori University Hospital
Tottori, Japan
- Toyama University Hospital
Toyama, Japan
- Vu University Medical Center
Amsterdam, Netherlands
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2017
- Primary completion
- 29 Jul 2021
- Completion
- 30 Sept 2026
- Last update posted
- 22 Feb 2023
- Registered enrollment
- 608
- Registry id
- NCT03088033
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.